“We are a serious investor in Ireland; we see it as a very attractive opportunity and place for us to do business. We’ve now got a very strong network of both portfolio companies and relationships in the corporate finance community.”
Duke Royalty announced a follow-on investment of around £7.7m into its existing royalty partner, Bakhchysarai Ireland (BIL), on Thursday. It said the new capital would support BIL’s second acquisition, PharmEng, trading as PE Global, which it described as “one of the leading” healthcare and life sciences recruiters in Ireland, with a growing presence in the UK.
Duke Royalty is unique in the UK, although its royalty model is well known in North America. Duke’s royalty income-based model provides cash generation and an attractive yield. Duke has the finance to grow the business and companies are becoming more aware of the attractions of royalty-based finance rather than bringing in private equity backers or floating on the stockmarket.
Duke Royalty brings royalty finance concept to Britain, investing millions in established SMEs in exchange of share of revenue.
Duke Royalty, a UK-quoted royalty financing company, is set to increase its portfolio in Ireland following the acquisition of British financier Capital Step in February.
The odds are that if you live in the UK and rest of Europe you have never heard of royalty finance. However, more than a decade after the 2008 financial crisis and on the back of a recent sell-off in global equity markets, the word around royalty financing is inevitably spreading rapidly.
Thanks to a relatively light-touch regulatory environment, the UK’s ‘alternative finance’ sector has flourished in the eight years or so since the first equity crowdfunding and peer-to-peer lending platforms came on stream.